WELLS FARGO & COMPANY/MN - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 162 filers reported holding ANIKA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$76,793
-73.8%
4,122
-63.5%
0.00%
Q2 2023$293,262
+22.2%
11,288
+35.1%
0.00%
Q1 2023$239,927
+1113.4%
8,354
+1150.6%
0.00%
Q4 2022$19,773
-40.1%
668
-52.3%
0.00%
Q3 2022$33,000
-15.4%
1,399
-21.3%
0.00%
Q2 2022$39,000
-90.3%
1,777
-88.9%
0.00%
Q1 2022$403,000
-44.3%
15,999
-20.8%
0.00%
Q4 2021$724,000
-51.1%
20,201
-41.9%
0.00%
Q3 2021$1,480,000
+8.0%
34,768
+9.8%
0.00%
Q2 2021$1,371,000
+242.8%
31,660
+222.9%
0.00%
Q1 2021$400,000
-95.5%
9,805
-95.0%
0.00%
-100.0%
Q4 2020$8,865,000
+29.7%
195,870
+1.4%
0.00%0.0%
Q3 2020$6,834,000
-8.9%
193,079
-2.9%
0.00%0.0%
Q2 2020$7,505,000
+9.1%
198,889
-16.5%
0.00%0.0%
Q1 2020$6,882,000
-54.1%
238,066
-17.6%
0.00%
-50.0%
Q4 2019$14,981,000
-18.6%
288,920
-13.9%
0.00%
-20.0%
Q3 2019$18,411,000
+65.0%
335,430
+22.1%
0.01%
+66.7%
Q2 2019$11,159,000
+69.2%
274,699
+26.0%
0.00%
+50.0%
Q1 2019$6,595,000
+1.9%
218,099
+13.2%
0.00%0.0%
Q4 2018$6,473,000
-29.1%
192,619
-11.0%
0.00%
-33.3%
Q3 2018$9,131,000
+34.6%
216,476
+2.1%
0.00%
+50.0%
Q2 2018$6,783,000
-37.4%
211,986
-2.7%
0.00%
-33.3%
Q1 2018$10,830,000
-6.7%
217,839
+1.2%
0.00%0.0%
Q4 2017$11,607,000
-4.7%
215,323
+2.6%
0.00%
-25.0%
Q3 2017$12,176,000
+47.0%
209,928
+25.0%
0.00%
+33.3%
Q2 2017$8,285,000
+14.4%
167,913
+0.7%
0.00%
+50.0%
Q1 2017$7,240,000
+779.7%
166,674
+891.4%
0.00%
Q4 2016$823,000
-14.4%
16,812
-16.2%
0.00%
Q3 2016$961,000
-0.4%
20,062
+11.4%
0.00%
Q2 2016$965,000
-29.0%
18,011
-40.8%
0.00%
-100.0%
Q1 2016$1,360,000
+93.7%
30,412
+65.2%
0.00%
Q4 2015$702,000
+29.5%
18,408
+7.9%
0.00%
Q3 2015$542,000
-21.3%
17,056
-18.3%
0.00%
Q2 2015$689,000
-46.6%
20,876
-33.4%
0.00%
Q1 2015$1,290,000
+81.2%
31,336
+79.2%
0.00%
Q4 2014$712,000
-20.4%
17,482
-28.5%
0.00%
Q3 2014$895,000
-54.1%
24,455
-41.9%
0.00%
-100.0%
Q2 2014$1,952,000
+9.2%
42,127
-3.2%
0.00%0.0%
Q1 2014$1,788,000
-29.0%
43,501
-34.0%
0.00%0.0%
Q4 2013$2,517,000
+35.6%
65,960
-15.1%
0.00%0.0%
Q3 2013$1,856,000
+15.9%
77,680
-17.5%
0.00%0.0%
Q2 2013$1,601,00094,2000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders